Pulmonary Hemorrhage and Vasculitis

Published on 13/02/2015 by admin

Filed under Cardiovascular

Last modified 13/02/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1656 times

CHAPTER 101 Pulmonary Hemorrhage and Vasculitis

A large number of conditions may result in pulmonary hemorrhage (Table 101-1). Broadly speaking, pulmonary hemorrhage may originate in the airways or lung parenchyma. Airway-related pulmonary hemorrhage is commonly the result of bronchitis, bronchiectasis, or malignancy, whereas parenchymal hemorrhage may result from pulmonary infarction, necrotizing pneumonias, toxic inhalational injury, malignancy, or causes of diffuse alveolar hemorrhage, with or without pulmonary vasculitis.

TABLE 101-1 Differential Diagnosis of Pulmonary Hemorrhage

Cause Features
Diffuse alveolar hemorrhage with capillaritis
Diffuse alveolar hemorrhage without capillaritis
Other Pulmonary arteriovenous malformation


Etiology and Pathophysiology

Diffuse alveolar hemorrhage (DAH) is present when the cause of the hemorrhage primarily affects the alveolar capillary surface. Causes of DAH may be divided into conditions associated with inflammation of the pulmonary capillaries, referred to as capillaritis, and those without capillaritis, so-called bland DAH (see Table 101-1). Pulmonary capillaritis refers to alveolar interstitial inflammation consisting of neutrophil accumulation associated with fibrinoid necrosis, producing injury to the basement membrane and resulting in leaky capillaries. Repeated bouts of inflammation and hemorrhage result in the deposition of hemosiderin-laden macrophages. In patients with bland DAH, red blood cells fill the alveoli in the absence of capillary inflammation. Note that there is occasionally some overlap in this classification system; Goodpasture syndrome, collagen vascular disease, and systemic lupus erythematosus may be associated with pulmonary hemorrhage with or without pulmonary capillaritis. For DAH with capillaritis, autoantibodies directed against the alveolar basement membrane produces direct damage or basement membrane injury results from immune complex deposition.


The histopathologic hallmark of vasculitis is the presence of angiocentric inflammation, usually extending through all layers of blood vessel walls. Fibrinoid necrosis and perivascular fibrosis are also commonly present, and may ultimately lead to vascular obliteration and occlusion. Both leukocytoclastic (neutrophil-predominant) and granulomatous (lymphocyte-predominant) vasculitic patterns may occur. Most pulmonary vasculitides share the common pathogenesis of immune complex deposition in the vessel wall, with activation of complement and cellular chemotaxis, leading to an enzymatic and inflammatory cascade that ultimately produces vascular damage. The whole process may be antigen-driven, which may explain the association of a number of vasculitides with viral infections and collagen vascular disorders. However, some granulomatous vasculitides may be the result of cell-mediated immunity rather than immune complex deposition. A number of vasculitides may affect the thorax, the lung in particular. The main histopathologic derangement of vasculitides affecting the lung is capillaritis, perhaps associated with inflammation of slightly larger vessels (Table 101-2).

TABLE 101-2 Common Causes of Pulmonary Vasculitis

Location Cause
Large vessels (aorta and major branch vessels)
Medium-sized vessels (visceral arteries)*
Small vessels (arterioles, capillaries, venules, distal intraparenchymal small arteries leading to arterioles)

* Some overlap in level of involvement may occur, particularly with either large or small vessel vasculitides involving medium-sized vessels.

Visceral arteries = coronary, hepatic, mesenteric, and renal arteries


First described in 1936, Wegener granulomatosis (WG) is a clinical syndrome characterized by a necrotizing granulomatous vasculitis involving the upper and lower respiratory tract and kidneys. WG is the most common vasculitis to affect the lungs.

Imaging Techniques and Findings


Chest radiographs are abnormal in up to 85% of patients with WG at some point during the course of the illness. The most characteristic imaging manifestation of WG is multiple, usually bilateral, nodules or masses typically measuring 2 to 4 cm, often associated with cavitation (Fig. 101-2). Pulmonary opacities and cavities in patients with WG may occasionally be much larger. WG-related pulmonary cavities often have a rather thick, irregular internal wall, and air-fluid levels are occasionally seen. Ground-glass opacity surrounding the cavities is a frequent finding and is usually caused by adjacent alveolitis or pulmonary hemorrhage.


Thoracic CT scanning in patients with WG also typically shows multiple bilateral nodules and/or masses,1 and is far more sensitive for the detection of cavitation than chest radiography. In fact, most nodules measuring more than 2 cm in patients with WG will show cavitation on CT (Fig. 101-3). Nodules and cavities in patients with WG have no particular zonal predilection, and are somewhat randomly distributed throughout the lungs.

Patchy multifocal or diffuse ground-glass opacities, often with areas of consolidation,1 is the second most common thoracic imaging manifestation of WG, and may occur in the absence of pulmonary nodules. These opacities are usually the result of pulmonary hemorrhage. Occasionally, areas of consolidation may be subpleural or peribronchiolar in distribution, simulating organizing pneumonia; the so-called atoll or reverse halo sign may also be seen (Fig. 101-4).

Tracheobronchial wall thickening and narrowing may be present in patients with WG,1 and may even lead to atelectasis. Typically, airway involvement in patients with WG predominates in the subglottic region and extends a variable distance caudally (Fig. 101-5). The airway wall thickening is circumferential and often nodular and irregular, occasionally resulting in tracheobronchial stenosis. The tracheobronchial thickening may occasionally calcify.

Pleural effusions and lymphadenopathy may occur in patients with WG, but are nonspecific findings and are relatively uncommon overall.

Pulmonary parenchymal opacities in patients with WG may resolve during treatment. Cavities may occasionally even enlarge during treatment, although wall thickness usually becomes progressively thinner and the internal wall character becomes smoother.


Microscopic polyangiitis is a small-vessel vasculitis2 that closely resembles polyarteritis nodosa, except that the latter usually involves medium-sized vessels, often involves abdomen viscera, and rarely produces DAH.

Manifestations of Disease

Clinical Presentation

Buy Membership for Cardiovascular Category to continue reading. Learn more here